View ICR - OIRA Conclusion

0910-0863 201811-0910-001
Active
HHS/FDA CDER
Surveys and Interviews with Investigational New Drug Sponsors to Assess Current Communication Practices with FDA Review Staff Under the Sixth Authorization of the Prescription Drug User Fee Act
New collection (Request for a new OMB Control Number)   No
Regular
Approved with change 12/14/2018
Retrieve Notice of Action (NOA) 11/19/2018
  Inventory as of this Action Requested Previously Approved
12/31/2021 36 Months From Approved
600 600 0
701 701 0
0 0 0